TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Craig Hockenberry’s Oct. 28 blog post recounts his lymphoma treatment, including chemotherapy, a bout of pneumonia and ongoing nerve damage. He says his strength began returning after his final infusions in May and describes later sensations that he and his doctors believe may signal nerve recovery; the post excerpt does not establish his current medical status or outcome.
Craig Hockenberry, writing from a hospital bed in a personal health update published October 28, described his experience with lymphoma treatment, including chemotherapy, pneumonia and persistent nerve problems. He said his strength and stamina began to return after his final infusions in May, and he later felt a new sensation in his legs that he and his doctors interpreted as a possible sign of nerve recovery.
Hockenberry said an early part of treatment involved weekly lumbar punctures over a six-week course that ended in January. During the procedures, clinicians withdrew spinal fluid and replaced it with methotrexate, he wrote. He reported severe headaches afterward, which eased when he lay flat, and said the headaches subsided after the punctures ended. The post does not identify the hospital or provide details of his diagnosis beyond describing it as lymphoma.
He later received infusions of bendamustine and rituximab on a 28-day cycle. Hockenberry described altered taste, fatigue, muscle loss and a weight loss of about 50 pounds over a couple of months. He said nausea and hair loss were not major effects for him, although his hair lost its usual body. He also wrote that he adapted his eating habits and at one point ate five meals a day.
In March, after an infusion, he developed pneumonia that he described as affecting people with weakened immune systems. He said his blood oxygen fell below 90% and his Apple Watch alerted him to an episode of atrial fibrillation. According to Hockenberry, antibiotics treated the pneumonia. His doctor offered to skip the next chemotherapy cycle, but Hockenberry said he chose to continue. He finished the infusions in May and later reported gradually increasing the distance of his daily walks.
Treatment Effects and Recovery
The account offers a first-person description of how lymphoma treatment affected daily function, from taste and appetite changes to fatigue, weight loss and difficulty walking. It also documents a serious complication that Hockenberry said occurred during treatment: pneumonia alongside low blood oxygen and an alert for atrial fibrillation. These are his reported experiences, not a substitute for clinical guidance or a description of how other patients will respond.
His later account of improved stamina and unusual sensations in his legs gives readers a view of recovery after chemotherapy, while underscoring that recovery can be gradual. The post does not say that his lymphoma is in remission or that the nerve damage has resolved. The distinction matters: the update describes changes he noticed and his interpretation of them, rather than a confirmed treatment outcome.
Products Worth Considering
Bowflex SelectTech 840 Adjustable Kettlebell
Oral-B iO Series 3 Rechargeable Electric Toothbrush for Adults, Black
Levoit Core 400S-P Smart Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
From Spinal Treatment to Infusions
Hockenberry’s account traces treatment across several months. He wrote that weekly spinal procedures ended at the end of January, followed by recurring chemotherapy infusions on a 28-day schedule. The first week after an infusion was especially difficult for him; he said the effects of steroids given with treatment wore off by the weekend, and he generally felt more like himself by the middle of the second week.
He also described nerve damage that was present before the lymphoma was discovered. Tingling and numbness, along with impaired balance, made stairs difficult. He used walking sticks and tried to take daily walks, even when he could manage only a slow shuffle. After completing infusions in May, he said walks grew from a quarter-mile to a mile. A few weeks later, bending his head forward brought a new sensation to the backs of his legs, which he viewed as a possible change in the condition of his nerves.
“Everyone experiences chemotherapy differently.”
— Craig Hockenberry, in his October 28 blog post
What the Update Does Not Confirm
The account is a personal report, not a medical record. It does not provide the lymphoma subtype, stage, test results, treatment response, or a current assessment from Hockenberry’s medical team. Although he describes sensations that he and his doctors took as a possible indication of nerve repair, the post excerpt does not confirm the cause or extent of any recovery.
The source text ends mid-sentence as Hockenberry begins to speculate about what may have caused the change in his spine. That means the available material does not include his full explanation or any further update. It also does not clarify whether he has had additional treatment, follow-up scans or other complications since May.
Further Medical Updates Await
No future appointment, test result or treatment milestone is specified in the available post. Any clearer picture of Hockenberry’s current health would depend on further information from him or his medical team, including whether the lymphoma responded to treatment and how his nerve symptoms have changed. Until then, the update supports only a limited conclusion: he reported finishing infusions in May and described some improvement in strength and walking afterward.
Key Questions
Who shared the health update?
Craig Hockenberry published the account on Furbo.org on October 28, 2026. It is a first-person description of his treatment and recovery.
What treatment did Hockenberry describe?
He wrote about a six-week course of weekly lumbar punctures involving methotrexate, followed by infusions of bendamustine and rituximab on a 28-day cycle.
What complications did he report?
Hockenberry described severe headaches after the spinal procedures, fatigue, muscle loss, altered taste and substantial weight loss. In March, he said he developed pneumonia, had blood oxygen below 90% and received an Apple Watch alert for an episode of atrial fibrillation.
Did Hockenberry confirm that his nerves recovered?
No. He described new sensations in his legs that he and his doctors believed could indicate nerve repair, but the available post does not confirm the extent or cause of recovery.
Is his lymphoma in remission?
The available account does not say whether Hockenberry’s lymphoma is in remission, provide test results or describe his current treatment status.
Source: hn
